Serum insulin-like growth factors in normal pregnancy and in pregnancies complicated by preeclampsia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 82, Issue 11, 2003, Pages 1004-1009

  Hübinette, Anna ^a   Lichtenstein, Paul ^a   Brismar, Kerstin ^a   Vatten, Lars ^b   Jacobsen, Geir ^b   Ekbom, Anders ^a   Cnattingius, Sven ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b University Medical Center   (Norway)

Author keywords

Breast cancer; Insulin like growth factor; Insulin like growth factor binding protein; Longitudinal study; Preeclampsia

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3;

ADULT; ARTICLE; BLOOD SAMPLING; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GESTATION PERIOD; HUMAN; INSULIN BLOOD LEVEL; PREECLAMPSIA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BINDING;

ADULT; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LONGITUDINAL STUDIES; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES;

EID: 0142209220     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0412.2003.00034.x     Document Type: Article

References (23)

1. Giudice LC, Martina NA, Crystal RA, Tazuke S, Druzin M. Insulin-like growth factor binding protein-1 at the maternal-fetal interface and insulin-like growth factor-I, insulin-like growth factor- II, and insulin-like growth factor binding protein-1 in the circulation of women with severe preeclampsia. Am J Obstet Gynecol 1997; 176: 751-7; 757-8 (discussion).
2. Halhali A, Tovar AR, Torres N, Bourges H, Garabedian M, Larrea F. Preeclampsia is associated with low circulating levels of insulin-like growth factor I and 1,25-dihydroxy-vitamin D in maternal and umbilical cord compartments. J Clin Endocrinol Metab 2000; 85: 1828-33.
3. Innes KE, Byers TE. Preeclampsia and breast cancer risk. Epidemiology 1999; 10: 722-32.
4. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet 1992; 340: 1015-8.
5. Ekbom A, Hsieh CC, Lipworth L, Adami HQ, Trichopoulos D. Intrauterine environment and breast cancer risk in women: a population- based study. J Natl Cancer Inst 1997; 89: 71-6.
6. Bohlke K, Cramer DW, Trichopoulos D, Mantzoros CS. Insulin-like growth factor-I in relation to premenopausal ductal carcinoma in situ of the breast. Epidemiology 1998; 9: 570-3.
7. Hankinson SE, Willett WC, Colditz GA, Hunter DJ, Michaud DS et al. Circulating concentrations of insulin-like growth factor-I and risk of breast cancer. Lancet 1998; 351: 1393-6.
8. Sachdev D, Yee D. The IGF system and breast cancer. Endocr Relat Cancer 2001; 8: 197-209.
9. Westley BR, May FE. Role of insulin-like growth factors in steroid modulated proliferation. J Steroid Biochem Mol Biol 1994; 51: 1-9.
10. Lewitt MS, Scott FP, Clarke NM, Wu T, Sinosich MJ, Baxter RC. Regulation of insulin-like growth factor-binding protein-3 ternary complex formation in pregnancy. J Endocrinol 1998; 159: 265-74.
11. Grobman WA, Kazer RR. Serum insulin, insulin-like growth factor-I, and insulin-like growth factor binding protein-1 in women who develop preeclampsia. Obstet Gynecol 2001; 97: 521-6.
12. Yu H, Mistry J, Nicar MJ, Khosravi MJ, Diamandis A, van Doorn J et al. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin- like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation. J Clin Laboratory Anal 1999; 13: 166-72.
13. Hills FA, English J, Chard T. Circulating levels of IGF-I and IGF-binding protein-1 throughout pregnancy: relation to birthweight and maternal weight. J Endocrinol 1996; 148: 303-9.
14. Langford KS, Nicolaides KH, Jones J, Abbas A, McGregor AM, Miell JP. Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. J Clin Endocrinol Metab 1995; 80: 21-7.
15. Reece EA, Wiznitzer A, Le E, Homko CJ, Behrman H, Spencer EM. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol 1994; 84: 88-95.
16. Holmes RP, Holly JM, Soothill PW. A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses. Br J Obstet Gynaecol 1998; 105: 1273-8.
17. Bakketeig LS, Jacobsen G, Hoffman HJ, Lindmark G, Bergsjo P, Molne K et al. Pre-pregnancy risk factors of small-for-gestational age births among parous women in Scandinavia. Acta Obstet Gynecol Scand 1993; 72: 273-9.
18. Davey DA, MacGillivray I. The classification and definition of the hypertensive disorders of pregnancy. Am J Obstet Gynecol 1988; 158: 892-8.
19. Hilding A, Hall K, Wivall-Helleryd IL, Saaf M, Melin AL, Thoren M. Serum levels of insulin-like growth factor I in 152 patients with growth hormone deficiency, aged 19-82 years, in relation to those in healthy subjects. J Clin Endocrinol Metab 1999; 84: 2013-9.
20. Wang HS, Lim J, English J, Irvine L, Chard T. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endocrinol 1991; 129: 459-64.
21. Vakharia D, Mizejewski GJ. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer. Breast Cancer Res Treat 2000; 63: 41-52.
22. Yaron Y, Cherry M, Kramer RL, O'Brien JE, Hallak M, Johnson MP et al. Second-trimester maternal serum marker screening: maternal serum alpha- fetoprotein, beta-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome. Am J Obstet Gynecol 1999; 181: 968-74.
23. Cohn BA, Cirillo PM, Christianson RE, van den Berg BJ, Siiteri PK. Placental characteristics and reduced risk of maternal breast cancer. J Natl Cancer Inst 2001; 93: 1133-40.